Cargando…
Recurrent sudden sensorineural hearing loss—A literature review
OBJECTIVE: Sudden sensorineural hearing loss (SSNHL) is one of the few emergent otologic conditions. Although more than half of all patients would benefit from timely treatment, recurrence occasionally develops unexpectedly. The aim of our study is to evaluate the recurrence rate after SSNHL, and pr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194968/ https://www.ncbi.nlm.nih.gov/pubmed/35734068 http://dx.doi.org/10.1002/lio2.828 |
_version_ | 1784726861792673792 |
---|---|
author | Zhang, Bang‐Yan Wang, Yu‐Chien Chan, Kai‐Chieh |
author_facet | Zhang, Bang‐Yan Wang, Yu‐Chien Chan, Kai‐Chieh |
author_sort | Zhang, Bang‐Yan |
collection | PubMed |
description | OBJECTIVE: Sudden sensorineural hearing loss (SSNHL) is one of the few emergent otologic conditions. Although more than half of all patients would benefit from timely treatment, recurrence occasionally develops unexpectedly. The aim of our study is to evaluate the recurrence rate after SSNHL, and present the prognosis after first‐episode and recurrent SSNHL. METHODS: A literature search was conducted of the PubMed and Embase electronic databases. RESULTS: Seven studies with a total of 3781 patients were included, and 96 patients experienced recurrence. The recurrence rate ranged between 1.4% and 17%. The average time to recurrence was about 2 years in most studies. The majority of the studies reported using systemic steroids for treating first‐episode SSNHL, and one study used a plasma expander in patients with recurrent SSNHL. The recovery rate for first‐episode patients was 58%–79%, while that for recurrent SSNHL ranged widely, from 21% to 86%. There were no common risk factors for SSNHL recurrence among the studies, although low‐frequency hearing loss, the presence of tinnitus during follow‐up, and an increased neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio have been proposed. CONCLUSION: Understanding the recurrence rate, risk factors, and prognosis after recurrence of SSHNL is crucial for comprehensive medical care; in this respect, further prospective studies with long‐term follow‐up may be instructive. LEVEL OF EVIDENCE: 4 |
format | Online Article Text |
id | pubmed-9194968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91949682022-06-21 Recurrent sudden sensorineural hearing loss—A literature review Zhang, Bang‐Yan Wang, Yu‐Chien Chan, Kai‐Chieh Laryngoscope Investig Otolaryngol Otology, Neurotology, and Neuroscience OBJECTIVE: Sudden sensorineural hearing loss (SSNHL) is one of the few emergent otologic conditions. Although more than half of all patients would benefit from timely treatment, recurrence occasionally develops unexpectedly. The aim of our study is to evaluate the recurrence rate after SSNHL, and present the prognosis after first‐episode and recurrent SSNHL. METHODS: A literature search was conducted of the PubMed and Embase electronic databases. RESULTS: Seven studies with a total of 3781 patients were included, and 96 patients experienced recurrence. The recurrence rate ranged between 1.4% and 17%. The average time to recurrence was about 2 years in most studies. The majority of the studies reported using systemic steroids for treating first‐episode SSNHL, and one study used a plasma expander in patients with recurrent SSNHL. The recovery rate for first‐episode patients was 58%–79%, while that for recurrent SSNHL ranged widely, from 21% to 86%. There were no common risk factors for SSNHL recurrence among the studies, although low‐frequency hearing loss, the presence of tinnitus during follow‐up, and an increased neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio have been proposed. CONCLUSION: Understanding the recurrence rate, risk factors, and prognosis after recurrence of SSHNL is crucial for comprehensive medical care; in this respect, further prospective studies with long‐term follow‐up may be instructive. LEVEL OF EVIDENCE: 4 John Wiley & Sons, Inc. 2022-05-26 /pmc/articles/PMC9194968/ /pubmed/35734068 http://dx.doi.org/10.1002/lio2.828 Text en © 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Otology, Neurotology, and Neuroscience Zhang, Bang‐Yan Wang, Yu‐Chien Chan, Kai‐Chieh Recurrent sudden sensorineural hearing loss—A literature review |
title | Recurrent sudden sensorineural hearing loss—A literature review |
title_full | Recurrent sudden sensorineural hearing loss—A literature review |
title_fullStr | Recurrent sudden sensorineural hearing loss—A literature review |
title_full_unstemmed | Recurrent sudden sensorineural hearing loss—A literature review |
title_short | Recurrent sudden sensorineural hearing loss—A literature review |
title_sort | recurrent sudden sensorineural hearing loss—a literature review |
topic | Otology, Neurotology, and Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194968/ https://www.ncbi.nlm.nih.gov/pubmed/35734068 http://dx.doi.org/10.1002/lio2.828 |
work_keys_str_mv | AT zhangbangyan recurrentsuddensensorineuralhearinglossaliteraturereview AT wangyuchien recurrentsuddensensorineuralhearinglossaliteraturereview AT chankaichieh recurrentsuddensensorineuralhearinglossaliteraturereview |